SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-129357
Filing Date
2024-05-02
Accepted
2024-05-02 16:07:01
Documents
15
Period of Report
2024-04-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d801460d8k.htm   iXBRL 8-K 32156
2 EX-99.1 d801460dex991.htm EX-99.1 9118
6 GRAPHIC g801460dsp005.jpg GRAPHIC 3369
  Complete submission text file 0001193125-24-129357.txt   182011

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vor-20240430.xsd EX-101.SCH 2849
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vor-20240430_lab.xml EX-101.LAB 19499
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vor-20240430_pre.xml EX-101.PRE 12156
18 EXTRACTED XBRL INSTANCE DOCUMENT d801460d8k_htm.xml XML 3894
Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39979 | Film No.: 24908193
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)